ASCO endorses SIO guideline for integrative Tx in breast cancer

August 4, 2018

(HealthDay)—The American Society for Clinical Oncology (ASCO) has endorsed the Society for Integrative Oncology (SIO) guideline on the use of integrative therapies during and after breast cancer treatment, according to a special article published online June 11 in the Journal of Clinical Oncology.

Gary H. Lyman, M.D., M.P.H., from the University of Washington in Seattle, and colleagues address the use of integrative therapies for the management of symptoms and side effects during and after breast cancer treatment. Interventions of interest included mind and body practices, natural products, and lifestyle modifications. The SIO systematic reviews focused on ; the guideline was reviewed by ASCO content experts for clinical accuracy and by ASCO methodologists for developmental rigor.

After determining that the SIO guideline recommendations were clear, thorough, and based on the most relevant scientific evidence, the ASCO Expert Panel endorsed the guideline with a few added points of discussion. Key recommendations include music , meditation, stress management, and yoga for reduction of anxiety/stress. For depression/mood disorders, meditation, relaxation, yoga, massage, and music therapy are recommended. To improve quality of life, meditation and yoga are recommended. For reducing chemotherapy-induced nausea and vomiting, acupressure and acupuncture are recommended. Because of a possibility of harm, acetyl-L-carnitine is not recommended to prevent chemotherapy-induced peripheral neuropathy.

"No strong evidence supports the use of ingested dietary supplements to manage related adverse effects," the authors write.

Several authors disclosed financial ties to the biopharmaceutical industry.

Explore further: ASCO endorses integrative oncology guidelines for breast cancer patients

More information: Abstract/Full Text

Related Stories

ASCO endorses integrative oncology guidelines for breast cancer patients

June 12, 2018
The first time Elizabeth Johnson told her oncologist she wanted to start folding integrative therapies into her breast cancer treatment regimen as a way to alleviate side effects, he told her "Sure, you can try, but it's ...

Growing body of evidence supports use of mind-body therapies in breast cancer treatment

April 24, 2017
In newly updated clinical guidelines from the Society for Integrative Oncology (SIO), researchers at Columbia University's Mailman School of Public Health and the Herbert Irving Comprehensive Cancer Center with an interdisciplinary ...

ASCO endorses ACS guideline for prostate CA survivor care

February 13, 2015
(HealthDay)—The American Society of Clinical Oncology (ASCO) has endorsed the American Cancer Society (ACS) Prostate Cancer Survivorship Care Guidelines, according to a report published online Feb. 9 in the Journal of Clinical ...

ASCO endorses guideline for radiation after prostatectomy

November 6, 2014
(HealthDay)—The American Society for Clinical Oncology (ASCO) has endorsed a recent guideline for adjuvant and salvage radiotherapy after prostatectomy. The endorsement was published online Nov. 3 in the Journal of Clinical ...

Report card on complementary therapies for breast cancer

October 27, 2014
Over eighty percent of breast cancer patients in the United States use complementary therapies following a breast cancer diagnosis, but there has been little science-based guidance to inform clinicians and patients about ...

New guidelines for treating form of advanced breast cancer

September 2, 2014
(HealthDay)—A leading group of oncologists has released updated guidelines for the treatment of the major form of advanced breast cancer.

Recommended for you

Why some cancers affect only young women

October 19, 2018
Among several forms of pancreatic cancer, one of them specifically affects women, often young. How is this possible, even though the pancreas is an organ with little exposure to sex hormones? This pancreatic cancer, known ...

Scientists to improve cancer treatment effectiveness

October 19, 2018
Together with researchers from the University of Nantes and the University of Reims Champagne-Ardenne in France, experts from the National Research Nuclear University MEPhI have recently developed a quantum dot-based microarray ...

Mutant cells colonize our tissues over our lifetime

October 18, 2018
By the time we reach middle age, more than half of the oesophagus in healthy people has been taken over by cells carrying mutations in cancer genes, scientists have uncovered. By studying normal oesophagus tissue, scientists ...

Study involving hundreds of patient samples may reveal new treatment options of leukemia

October 17, 2018
After more than five years and 672 patient samples, an OHSU research team has published the largest cancer dataset of its kind for a form of leukemia. The study, "Functional Genomic Landscape of Acute Myeloid Leukemia", published ...

A 150-year-old drug might improve radiation therapy for cancer

October 17, 2018
A drug first identified 150 years ago and used as a smooth-muscle relaxant might make tumors more sensitive to radiation therapy, according to a recent study led by researchers at The Ohio State University Comprehensive Cancer ...

Loss of protein p53 helps cancer cells multiply in 'unfavourable' conditions

October 17, 2018
Researchers have discovered a novel consequence of loss of the tumour protein p53 that promotes cancer development, according to new findings in eLife.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.